RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sensyne Health Stock

Sensyne Health P/E 2024

Sensyne Health P/E

197.16

Ticker

SENS.L

ISIN

GB00BYV3J755

WKN

A2N38D

As of Sep 6, 2024, Sensyne Health's P/E ratio was 197.16, a 0% change from the 0 P/E ratio recorded in the previous year.

The Sensyne Health P/E history

Sensyne Health Aktienanalyse

What does Sensyne Health do?

Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. History: Sensyne Health was founded by Lord Drayson, a British entrepreneur and former Minister for Science and Innovation. The company is based on the belief that the application of AI technologies in the healthcare industry can help improve medical care, make the healthcare system more efficient, and ultimately save lives. Business model: Sensyne Health offers a range of products and services based on AI technologies. The key business areas include: - Clinical research: Sensyne Health works closely with national health authorities and various hospitals to collect and analyze data that can be used in the development of new treatment options and the improvement of diagnostic processes. - Digital patient monitoring: The company develops advanced sensors and devices that allow doctors and nurses to monitor the health status of patients in real-time. By using AI algorithms, health problems can be detected and treated early. - AI-based analysis: Sensyne Health has extensive experience in applying AI technologies to medical data. The company uses its expertise to conduct complex data analysis that helps doctors and researchers gain new insights into diseases and their treatment options. Products: Sensyne Health offers a variety of products and solutions tailored to the needs of the healthcare industry. Here are some of the key products that the company offers: - Patient data platform: A cloud-based platform that allows hospitals and research institutions to collect, store, and analyze patient data. The use of AI algorithms automates and accelerates data analysis. - Hospital collaborations: Sensyne Health works with various hospitals in the UK and other countries to collect and analyze patient data. The data is then shared in anonymized form with researchers and life science companies to develop new insights and treatment options. - AI-based patient monitoring: Sensyne Health has developed a range of devices and sensors that allow doctors and nurses to monitor the health status of patients in real-time. The data is automatically evaluated, and the results are transmitted to the medical staff to quickly respond to changes in the patient's condition. Conclusion: Sensyne Health is a leading provider of AI-based solutions for the healthcare industry. The company specializes in data collection, analysis, and the development of new treatment options. Through its collaborations with hospitals and government agencies, Sensyne Health has access to a large amount of data that can lead to new insights and improve medical care in the future. Answer: Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. The company was founded by Lord Drayson, and it aims to use AI technologies to improve medical care, make healthcare more efficient, and save lives. Sensyne Health offers products and services in clinical research, digital patient monitoring, and AI-based analysis. The company's products include a patient data platform, collaborations with hospitals, and AI-based patient monitoring devices. Sensyne Health is focused on collecting and analyzing data to develop new treatment options and improve healthcare in the future. Sensyne Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Sensyne Health's P/E Ratio

The Price to Earnings (P/E) Ratio of Sensyne Health is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Sensyne Health's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Sensyne Health is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Sensyne Health’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Sensyne Health stock

What is the price-to-earnings ratio of Sensyne Health?

The price-earnings ratio of Sensyne Health is currently 197.16.

How has the price-earnings ratio of Sensyne Health changed compared to last year?

The price-to-earnings ratio of Sensyne Health has increased by 0% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Sensyne Health high compared to other companies?

Yes, the price-to-earnings ratio of Sensyne Health is high compared to other companies.

How does an increase in the price-earnings ratio of Sensyne Health affect the company?

An increase in the price-earnings ratio of Sensyne Health would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Sensyne Health affect the company?

A decrease in the price-earnings ratio of Sensyne Health would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Sensyne Health?

Some factors that influence the price-earnings ratio of Sensyne Health are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Sensyne Health pay?

Over the past 12 months, Sensyne Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensyne Health is expected to pay a dividend of 0 GBP.

What is the dividend yield of Sensyne Health?

The current dividend yield of Sensyne Health is .

When does Sensyne Health pay dividends?

Sensyne Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sensyne Health?

Sensyne Health paid dividends every year for the past 0 years.

What is the dividend of Sensyne Health?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sensyne Health located?

Sensyne Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sensyne Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sensyne Health from 9/6/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.

When did Sensyne Health pay the last dividend?

The last dividend was paid out on 9/6/2024.

What was the dividend of Sensyne Health in the year 2023?

In the year 2023, Sensyne Health distributed 0 GBP as dividends.

In which currency does Sensyne Health pay out the dividend?

The dividends of Sensyne Health are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sensyne Health

Our stock analysis for Sensyne Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensyne Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.